While identifying sentinel nodes with lymphoscintigraphy can have a significant impact on the treatment and outcome of breast cancer, the planar imaging technique is less than optimal for overweight women.
While identifying sentinel nodes with lymphoscintigraphy can have a significant impact on the treatment and outcome of breast cancer, the planar imaging technique is less than optimal for overweight women. Multiplanar SPECT/CT lymphoscintigraphy may change that.
Dr. Hedva Lerman and colleagues at Tel Aviv Sourasky Medical Center in Israel found that overall SPECT/CT lymphoscintigraphy detects more sentinel nodes not identified with planar imaging or intraoperative blue dye. In overweight women, however, the difference was statistically significant. (JNM 2007;48[2]:201-206).
"Obesity is a significant factor in why lymphoscintigraphy fails and leads to occasional-and unnecessary-full axillary lymph node dissection," Lerman said.
Researchers don't know exactly why planar imaging fails in overweight patients, but they speculate that adipose tissue in the lymph nodes may compromise the test's accuracy.
European Society of Breast Imaging Issues Updated Breast Cancer Screening Recommendations
April 24th 2024One of the recommendations from the European Society of Breast Imaging (EUSOBI) is annual breast MRI exams starting at 25 years of age for women deemed to be at high risk for breast cancer.
Study Reveals Benefits of Photon-Counting CT for Assessing Acute Pulmonary Embolism
April 23rd 2024In comparison to energy-integrating detector CT for the workup of suspected acute pulmonary embolism, the use of photon-counting detector CT reduced radiation dosing by 48 percent, according to newly published research.
Could a Newly FDA-Cleared C-Arm Device Bolster Efficiency for Interventional Radiologists?
April 22nd 2024In addition to advanced imaging quality and dose efficiency, the Philips Zenition 30 mobile C-arm device emphasizes personalized user profiles and automated customization to help reduce procedure time.